Identifying Gaps in the Locoregional Management of Early Breast Cancer: Highlights from the Kyoto Consensus Conference

[1]  M. Sabel.  Surgical considerations in early-stage breast cancer: lessons learned and future directions. , 2011, Seminars in radiation oncology.

[2]  M. Morrow.  Trends in the Surgical Treatment of Breast Cancer , 2010, The breast journal.

[3]  K. Gelmon,et al.  Ki67 in breast cancer: prognostic and predictive potential. , 2010, The Lancet. Oncology.

[4]  A. Luini,et al.  Breast-Conserving Surgery in BRCA1/2 Mutation Carriers: Are We Approaching an Answer? , 2009, Annals of Surgical Oncology.

[5]  A. Luini,et al.  A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancer. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  A. Rademaker,et al.  Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. , 2009, Journal of Clinical Oncology.

[7]  E. Darai,et al.  Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study. , 2009, Journal of Clinical Oncology.

[8]  Charles M. Perou,et al.  Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer , 2009, Journal of the National Cancer Institute.

[9]  A. Luini,et al.  Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3548 cases. , 2009, European journal of cancer.

[10]  E. Siegel,et al.  Stage migration with sentinel node biopsy in breast cancer. , 2009, American journal of surgery.

[11]  M. Morrow,et al.  Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  D. Roukos,et al.  Genetics and Personal Genomics for Personalized Breast Cancer Surgery: Progress and Challenges in Research and Clinical Practice , 2009, Annals of Surgical Oncology.

[13]  D. Evans,et al.  Prediction of the presence of invasive disease from the measurement of extent of malignant microcalcification on mammography and ductal carcinoma in situ grade at core biopsy. , 2009, Clinical radiology.

[14]  A. Soran,et al.  Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy. , 2009, Journal of the American College of Surgeons.

[15]  Medicina Nucleare.  Is complete axillary dissection necessary for all patients with positive findings on sentinel lymph node biopsy? Validation of a breast cancer nomogram for predicting the likelihood of a non -sentinel lymph node , 2009 .

[16]  J. Bevilacqua,et al.  Predictive Probability of Four Different Breast Cancer Nomograms for Nonsentinel Axillary Lymph Node Metastasis in Positive Sentinel Node Biopsy , 2009 .

[17]  A. Chagpar.  How Many Sentinel Lymph Nodes are Enough During Sentinel Lymph Node Dissection for Breast Cancer , 2009 .

[18]  I. Rubio,et al.  Removal of all radioactive sentinel nodes in breast cancer improves the detection of positive sentinel nodes , 2008, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[19]  M. Ross,et al.  How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer? , 2008, Cancer.

[20]  Barbara L. Smith,et al.  Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  V. Klimberg,et al.  Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy. , 2008, Journal of the American College of Surgeons.

[22]  Barbara L. Smith,et al.  Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  V. Brouste,et al.  Distinction between isolated tumor cells and micrometastases in breast cancer , 2008, Cancer.

[24]  J R Yarnold,et al.  The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial , 2008, The Lancet.

[25]  F. B. Sørensen,et al.  Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  D. McCready,et al.  Sentinel Nodes in Breast Cancer: Relevance of Axillary Level II Nodes and Optimal Number of Nodes that Need to Be Removed , 2008, Annals of Surgical Oncology.

[27]  G. Viale,et al.  Sentinel Node Biopsy Is Not a Standard Procedure in Ductal Carcinoma In Situ of the Breast: The Experience of the European Institute of Oncology on 854 Patients in 10 Years , 2008, Annals of surgery.

[28]  D. Santini,et al.  259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up , 2008, Breast Cancer Research and Treatment.

[29]  H. Bartelink,et al.  Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  G. Viani,et al.  Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials , 2007, Radiation oncology.

[31]  W. Woodward,et al.  Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy. , 2007, International journal of radiation oncology, biology, physics.

[32]  T. Julian,et al.  Is Sentinel Node Biopsy Necessary in Conservatively Treated DCIS? , 2007, Annals of Surgical Oncology.

[33]  J. Benson,et al.  Management of the axilla in women with breast cancer. , 2007, Breast.

[34]  B. Haffty.  4–50 Ipsilateral Breast Tumor Recurrence (IBTR) After Breast-Conserving Treatment for Early Breast Cancer: Risk Factors and Impact on Distant Metastases , 2007 .

[35]  D. Roukos,et al.  The Predominant Role of Surgery in the Prevention and New Trends in the Surgical Treatment of Women With BRCA1/2 Mutations , 2007, Annals of Surgical Oncology.

[36]  J. Peterse,et al.  Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  J. Bellon,et al.  A prospective study of conservative surgery without radiation therapy in select patients with Stage I breast cancer. , 2006, International journal of radiation oncology, biology, physics.

[38]  R. Collins,et al.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[39]  M. Morrow.  Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Breast Cancer: Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27 , 2006 .

[40]  Greg Yothers,et al.  Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. , 2005, The New England journal of medicine.

[41]  T. Julian,et al.  Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  Mitsuharu Miwa,et al.  Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer , 2005, Breast cancer.

[43]  Antoine Flahault,et al.  An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement , 2005, Breast Cancer Research and Treatment.

[44]  G. Hortobagyi,et al.  Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  Barbara L. Smith,et al.  Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. , 2004, The New England journal of medicine.

[46]  Melania Pintilie,et al.  Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. , 2004, The New England journal of medicine.

[47]  D. Nitti,et al.  Number of Metastatic Sentinel Nodes As Predictor of Axillary Involvement in Patients with Breast Cancer , 2004, Breast Cancer Research and Treatment.

[48]  D. Dabbs,et al.  The Optimal Number of Sentinel Lymph Nodes for Focused Pathologic Examination , 2004, The breast journal.

[49]  Hiram S. Cody,et al.  A Nomogram for Predicting the Likelihood of Additional Nodal Metastases in Breast Cancer Patients With a Positive Sentinel Node Biopsy , 2003, Annals of Surgical Oncology.

[50]  B. E. F. Isher,et al.  Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. , 2002 .

[51]  Norman Wolmark,et al.  Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[52]  Anthony Fyles,et al.  Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. , 2002, Journal of the National Cancer Institute.

[53]  R. Mansel,et al.  Sentinel Node Biopsy in Breast Cancer: ALMANAC Trial , 2001, World Journal of Surgery.

[54]  James Dignam,et al.  Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial , 1999, The Lancet.

[55]  David C. Smith,et al.  Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial , 1996, The Lancet.

[56]  A P Forrest,et al.  Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. , 1996, Lancet.